What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Pipeline Analysis

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1081118

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1081118

Market Study on Primary Hepatocytes: Cryopreserved Suspension Hepatocytes Hold Over 40% Market Share

PUBLISHED: April 15, 2022

PAGES: 316 Pages

DELIVERY TIME: 2-5 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

Primary Hepatocytes Market - Scope of Report

The latest publication by Persistence Market Research on the global primary hepatocytes market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for primary hepatocytes and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the primary hepatocytes market. The insights and information presented in this persistence market research study can be leveraged by shareholders in the primary hepatocytes market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the primary hepatocytes market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the primary hepatocytes market offers information divided into five important segments - product, species, application/assay, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

Cryopreserved Suspension Hepatocytes

Fresh Suspension Hepatocytes

3D (Spheroid) Hepatocytes

Expanded Hepatocytes (Plateable)

Non-characterized Hepatocytes

Species

Humans

Rats

Mice

Dogs

Monkeys

Horses

Others

Application/Assay

Cell Viability Assays

Cytochrome Enzyme Activity

High Content Cytotoxicity

Transporter Inhibition Assays

In Vitro Intrinsic Clearance

Phospholipids Assays

Others

End User

Biopharmaceutical Companies

Academic and Research Institutes

Contract Research Organizations

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

MEA

Key Questions Answered in Report

Which regions will continue to remain the most profitable markets for primary hepatocytes over the coming years?

How will changing trends impact the market?

How has the COVID-19 crisis impacted market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will impact the market?

How can companies in the primary hepatocytes industry avail themselves of the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the primary hepatocytes market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the primary hepatocytes market more accurate and reliable.

Product Code: PMRREP32880

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion And Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Key Inclusions

4.1. Product Adoption / Usage Analysis
4.2. Key Regulatory Scenario
4.3. PESTLE Analysis
4.4. Porters Analysis
4.5. Recent Product Launches & Approvals
4.6. Key Promotional Strategies by Manufacturers
4.7. Importance of cell-based assays in liver toxicity

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Expenditure Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Increasing drug discovery
- 5.2.2. Rapid growth in the biotechnology and biopharmaceutical industries
- 5.2.3. Stringent regulations for drug approvals
- 5.2.4. Advantages of primary cells over cell lines
- 5.2.5. Increasing number of biotech companies
5.3. Value Chain Analysis
5.4. Market Dynamics
- 5.4.1. Drivers
- 5.4.2. Restraints
- 5.4.3. Opportunity Analysis

6. COVID19 Crisis Analysis

6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 Economic analysis
6.4. COVID19 and Impact Analysis
- 6.4.1. By Product
- 6.4.2. By Species
- 6.4.3. By Application/Assay
- 6.4.4. By End User
- 6.4.5. By Region

7. Global Primary Hepatocytes Market Demand (in Volume) Analysis 2017-2021 and Forecast, 2022-2032

7.1. Historical Market (Volume) Analysis, 2017-2021
7.2. Current and Future Market (Volume) Projections, 2022-2032
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Primary Hepatocytes Market - Pricing Analysis

8.1. Country-wise & Regional Pricing Analysis by Product
8.2. Global Average Pricing Analysis Benchmark

9. Global Primary Hepatocytes Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

9.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
9.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
- 9.2.1. Y-o-Y Growth Trend Analysis
- 9.2.2. Absolute $ Opportunity Analysis

10. Global Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032, By Product

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume Analysis by Product, 2017-2021
10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast by Product, 2022-2032
- 10.3.1. Cryopreserved Suspension Hepatocytes
- 10.3.2. Fresh Suspension Hepatocytes
- 10.3.3. 3D (Spheroid) hepatocytes
- 10.3.4. Expanded hepatocytes (plateable)
- 10.3.5. Non-characterized hepatocytes
10.4. Market Attractiveness Analysis by Product

11. Global Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032, by Species

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis by Species, 2017-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Species, 2022-2032
- 11.3.1. Human
- 11.3.2. Rat
- 11.3.3. Mouse
- 11.3.4. Dog
- 11.3.5. Monkey
- 11.3.6. Horse
- 11.3.7. Others
11.4. Market Attractiveness Analysis by Species

12. Global Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032, by Application/Assay

12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis by Application/Assay, 2017-2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Application/Assay, 2022-2032
- 12.3.1. Cell Viability assay
- 12.3.2. Cytochrome enzyme activity
- 12.3.3. High Content Cytotoxicity
- 12.3.4. Transporter Inhibition Assay
- 12.3.5. In vitro intrinsic clearance
- 12.3.6. Phospholipoids Assay
- 12.3.7. Others
12.4. Market Attractiveness Analysis by Application/Assay

13. Global Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032, by End User

13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis by End User, 2017-2021
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2022-2032
- 13.3.1. Biopharmaceutical companies
- 13.3.2. Academic and Research institutes
- 13.3.3. Contract Research Organizations
13.4. Market Attractiveness Analysis by End User

14. Global Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032, by Region

14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume Analysis by Region, 2017-2021
14.3. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2022-2032
- 14.3.1. North America
- 14.3.2. Latin America
- 14.3.3. Europe
- 14.3.4. East Asia
- 14.3.5. South Asia
- 14.3.6. Oceania
- 14.3.7. Middle East and Africa (MEA)
14.4. Market Attractiveness Analysis by Region

15. North America Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032

15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume Analysis by Region, 2017-2021
15.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2022-2032
- 15.4.1. By Country
  - 15.4.1.1. U.S.
  - 15.4.1.2. Canada
- 15.4.2. By Product
- 15.4.3. By Species
- 15.4.4. By Application/Assay
- 15.4.5. By End User
15.5. Market Attractiveness Analysis
- 15.5.1. By Country
- 15.5.2. By Product
- 15.5.3. By Species
- 15.5.4. By Application/Assay
- 15.5.5. By End User
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis

16. Latin America Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032

16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume Analysis by Region, 2017-2021
16.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2022-2032
- 16.4.1. By Country
  - 16.4.1.1. Brazil
  - 16.4.1.2. Mexico
  - 16.4.1.3. Rest of Latin America
- 16.4.2. By Product
- 16.4.3. By Species
- 16.4.4. By Application/Assay
- 16.4.5. By End User
16.5. Market Attractiveness Analysis
- 16.5.1. By Country
- 16.5.2. By Product
- 16.5.3. By Species
- 16.5.4. By Application/Assay
- 16.5.5. By End User
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis

17. Europe Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032

17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Volume Analysis by Region, 2017-2021
17.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2022-2032
- 17.4.1. By Country
  - 17.4.1.1. Germany
  - 17.4.1.2. Italy
  - 17.4.1.3. France
  - 17.4.1.4. U.K.
  - 17.4.1.5. Spain
  - 17.4.1.6. BENELUX
  - 17.4.1.7. Russia
  - 17.4.1.8. Poland
  - 17.4.1.9. Rest of Europe
- 17.4.2. By Product
- 17.4.3. By Species
- 17.4.4. By Application/Assay
- 17.4.5. By End User
17.5. Market Attractiveness Analysis
- 17.5.1. By Country
- 17.5.2. By Product
- 17.5.3. By Species
- 17.5.4. By Application/Assay
- 17.5.5. By End User
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis

18. South Asia and Pacific Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032

18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) and Volume Analysis by Region, 2017-2021
18.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2022-2032
- 18.4.1. By Country
  - 18.4.1.1. India
  - 18.4.1.2. Thailand
  - 18.4.1.3. Indonesia
  - 18.4.1.4. Malaysia
  - 18.4.1.5. Rest of South Asia & Pacific
- 18.4.2. By Product
- 18.4.3. By Species
- 18.4.4. By Application/Assay
- 18.4.5. By End User
18.5. Market Attractiveness Analysis
- 18.5.1. By Country
- 18.5.2. By Product
- 18.5.3. By Species
- 18.5.4. By Application/Assay
- 18.5.5. By End User
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis

19. East Asia Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032

19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) and Volume Analysis by Region, 2017-2021
19.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2022-2032
- 19.4.1. By Country
  - 19.4.1.1. China
  - 19.4.1.2. Japan
  - 19.4.1.3. South Korea
- 19.4.2. By Product
- 19.4.3. By Species
- 19.4.4. By Application/Assay
- 19.4.5. By End User
19.5. Market Attractiveness Analysis
- 19.5.1. By Country
- 19.5.2. By Product
- 19.5.3. By Species
- 19.5.4. By Application/Assay
- 19.5.5. By End User
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis

20. Oceania Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032

20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Mn) and Volume Analysis by Region, 2017-2021
20.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2022-2032
- 20.4.1. By Country
  - 20.4.1.1. Australia
  - 20.4.1.2. New Zealand
- 20.4.2. By Product
- 20.4.3. By Species
- 20.4.4. By Application/Assay
- 20.4.5. By End User
20.5. Market Attractiveness Analysis
- 20.5.1. By Country
- 20.5.2. By Product
- 20.5.3. By Species
- 20.5.4. By Application/Assay
- 20.5.5. By End User
20.6. Key Market Participants - Intensity Mapping
20.7. Drivers and Restraints - Impact Analysis

21. Middle East and Africa Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032

21.1. Introduction
21.2. Pricing Analysis
21.3. Historical Market Size (US$ Mn) and Volume Analysis by Region, 2017-2021
21.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2022-2032
- 21.4.1. By Country
  - 21.4.1.1. GCC Countries
  - 21.4.1.2. Turkey
  - 21.4.1.3. Northern Africa
  - 21.4.1.4. South Africa
  - 21.4.1.5. Rest of Middle East and Africa
- 21.4.2. By Product
- 21.4.3. By Species
- 21.4.4. By Application/Assay
- 21.4.5. By End User
21.5. Market Attractiveness Analysis
- 21.5.1. By Country
- 21.5.2. By Product
- 21.5.3. By Species
- 21.5.4. By Application/Assay
- 21.5.5. By End User
21.6. Key Market Participants - Intensity Mapping
21.7. Drivers and Restraints - Impact Analysis

22. Country Level Primary Hepatocytes Market Analysis 2022 & 2032

22.1. Introduction
- 22.1.1. Market Value Proportion Analysis, By Top 5 Countries
- 22.1.2. Global VS. Country Growth Comparison
22.2. U.S. Primary Hepatocytes Market Analysis
- 22.2.1. By Product
- 22.2.2. By Species
- 22.2.3. By Application/Assay
- 22.2.4. By End User
22.3. Canada Primary Hepatocytes Market Analysis
- 22.3.1. By Product
- 22.3.2. By Species
- 22.3.3. By Application/Assay
- 22.3.4. By End User
22.4. Mexico Primary Hepatocytes Market Analysis
- 22.4.1. By Product
- 22.4.2. By Species
- 22.4.3. By Application/Assay
- 22.4.4. By End User
22.5. Brazil Primary Hepatocytes Market Analysis
- 22.5.1. By Product
- 22.5.2. By Species
- 22.5.3. By Application/Assay
- 22.5.4. By End User
22.6. Germany Primary Hepatocytes Market Analysis
- 22.6.1. By Product
- 22.6.2. By Species
- 22.6.3. By Application/Assay
- 22.6.4. By End User
22.7. Italy Primary Hepatocytes Market Analysis
- 22.7.1. By Product
- 22.7.2. By Technology
- 22.7.3. By Distribution channel
22.8. France Primary Hepatocytes Market Analysis
- 22.8.1. By Product
- 22.8.2. By Species
- 22.8.3. By Application/Assay
- 22.8.4. By End User
22.9. U.K. Primary Hepatocytes Market Analysis
- 22.9.1. By Product
- 22.9.2. By Species
- 22.9.3. By Application/Assay
- 22.9.4. By End User
22.10. Spain Primary Hepatocytes Market Analysis
- 22.10.1. By Product
- 22.10.2. By Species
- 22.10.3. By Application/Assay
- 22.10.4. By End User
22.11. BENELUX Primary Hepatocytes Market Analysis
- 22.11.1. By Product
- 22.11.2. By Species
- 22.11.3. By Application/Assay
- 22.11.4. By End User
22.12. Russia Primary Hepatocytes Market Analysis
- 22.12.1. By Product
- 22.12.2. By Species
- 22.12.3. By Application/Assay
- 22.12.4. By End User
22.13. Poland Primary Hepatocytes Market Analysis
- 22.13.1. By Product
- 22.13.2. By Species
- 22.13.3. By Application/Assay
- 22.13.4. By End User
22.14. India Primary Hepatocytes Market Analysis
- 22.14.1. By Product
- 22.14.2. By Species
- 22.14.3. By Application/Assay
- 22.14.4. By End User
22.15. Thailand Primary Hepatocytes Market Analysis
- 22.15.1. By Product
- 22.15.2. By Species
- 22.15.3. By Application/Assay
- 22.15.4. By End User
22.16. Indonesia Primary Hepatocytes Market Analysis
- 22.16.1. By Product
- 22.16.2. By Species
- 22.16.3. By Application/Assay
- 22.16.4. By End User
22.17. Malaysia Primary Hepatocytes Market Analysis
- 22.17.1. By Product
- 22.17.2. By Species
- 22.17.3. By Application/Assay
- 22.17.4. By End User
22.18. China Primary Hepatocytes Market Analysis
- 22.18.1. By Product
- 22.18.2. By Species
- 22.18.3. By Application/Assay
- 22.18.4. By End User
22.19. Japan Primary Hepatocytes Market Analysis
- 22.19.1. By Product
- 22.19.2. By Species
- 22.19.3. By Application/Assay
- 22.19.4. By End User
22.20. South Korea Primary Hepatocytes Market Analysis
- 22.20.1. By Product
- 22.20.2. By Species
- 22.20.3. By Application/Assay
- 22.20.4. By End User
22.21. Australia Primary Hepatocytes Market Analysis
- 22.21.1. By Product
- 22.21.2. By Species
- 22.21.3. By Application/Assay
- 22.21.4. By End User
22.22. New Zealand Primary Hepatocytes Market Analysis
- 22.22.1. By Product
- 22.22.2. By Species
- 22.22.3. By Application/Assay
- 22.22.4. By End User
22.23. GCC Primary Hepatocytes Market Analysis
- 22.23.1. By Product
- 22.23.2. By Species
- 22.23.3. By Application/Assay
- 22.23.4. By End User
22.24. Turkey Primary Hepatocytes Market Analysis
- 22.24.1. By Product
- 22.24.2. By Species
- 22.24.3. By Application/Assay
- 22.24.4. By End User
22.25. Northern Africa Primary Hepatocytes Market Analysis
- 22.25.1. By Product
- 22.25.2. By Species
- 22.25.3. By Application/Assay
- 22.25.4. By End User
22.26. South Africa Primary Hepatocytes Market Analysis
- 22.26.1. By Product
- 22.26.2. By Species
- 22.26.3. By Application/Assay
- 22.26.4. By End User

23. Market Structure Analysis

23.1. Market Analysis by Tier of Companies
23.2. Market Share Analysis of Top Players
23.3. Market Presence Analysis

24. Competition Analysis

24.1. Competition Dashboard
24.2. Competition Benchmarking
24.3. Competition Deep Dive
- 24.3.1. Thermo Fisher Scientific
  - 24.3.1.1. Overview & Key financials
  - 24.3.1.2. Product Portfolio
  - 24.3.1.3. Profitability by Market Segments (Product/Channel/Region)
  - 24.3.1.4. Sales Footprint
  - 24.3.1.5. Analysis Commentary
  - 24.3.1.6. Strategy Overview
- 24.3.2. Corning Inc.
  - 24.3.2.1. Overview & Key financials
  - 24.3.2.2. Product Portfolio
  - 24.3.2.3. Profitability by Market Segments (Product/Channel/Region)
  - 24.3.2.4. Sales Footprint
  - 24.3.2.5. Analysis Commentary
  - 24.3.2.6. Strategy Overview
- 24.3.3. Lonza
  - 24.3.3.1. Overview & Key financials
  - 24.3.3.2. Product Portfolio
  - 24.3.3.3. Profitability by Market Segments (Product/Channel/Region)
  - 24.3.3.4. Sales Footprint
  - 24.3.3.5. Analysis Commentary
  - 24.3.3.6. Strategy Overview
- 24.3.4. Axol Bioscience Ltd.
  - 24.3.4.1. Overview & Key financials
  - 24.3.4.2. Product Portfolio
  - 24.3.4.3. Profitability by Market Segments (Product/Channel/Region)
  - 24.3.4.4. Sales Footprint
  - 24.3.4.5. Analysis Commentary
  - 24.3.4.6. Strategy Overview
- 24.3.5. LifeNet Health
  - 24.3.5.1. Overview & Key financials
  - 24.3.5.2. Product Portfolio
  - 24.3.5.3. Profitability by Market Segments (Product/Channel/Region)
  - 24.3.5.4. Sales Footprint
  - 24.3.5.5. Analysis Commentary
  - 24.3.5.6. Strategy Overview
- 24.3.6. SEKISUI XenoTech, LLC
  - 24.3.6.1. Overview & Key financials
  - 24.3.6.2. Product Portfolio
  - 24.3.6.3. Profitability by Market Segments (Product/Channel/Region)
  - 24.3.6.4. Sales Footprint
  - 24.3.6.5. Analysis Commentary
  - 24.3.6.6. Strategy Overview
- 24.3.7. Cytes Biotechnologies
  - 24.3.7.1. Overview & Key financials
  - 24.3.7.2. Product Portfolio
  - 24.3.7.3. Profitability by Market Segments (Product/Channel/Region)
  - 24.3.7.4. Sales Footprint
  - 24.3.7.5. Analysis Commentary
  - 24.3.7.6. Strategy Overview
- 24.3.8. Cell Biologics, Inc.
  - 24.3.8.1. Overview & Key financials
  - 24.3.8.2. Product Portfolio
  - 24.3.8.3. Profitability by Market Segments (Product/Channel/Region)
  - 24.3.8.4. Sales Footprint
  - 24.3.8.5. Analysis Commentary
  - 24.3.8.6. Strategy Overview
- 24.3.9. ZenBio, Inc.
  - 24.3.9.1. Overview & Key financials
  - 24.3.9.2. Product Portfolio
  - 24.3.9.3. Profitability by Market Segments (Product/Channel/Region)
  - 24.3.9.4. Sales Footprint
  - 24.3.9.5. Analysis Commentary
  - 24.3.9.6. Strategy Overview
- 24.3.10. BioIVT.
  - 24.3.10.1. Overview & Key financials
  - 24.3.10.2. Product Portfolio
  - 24.3.10.3. Profitability by Market Segments (Product/Channel/Region)
  - 24.3.10.4. Sales Footprint
  - 24.3.10.5. Analysis Commentary
  - 24.3.10.6. Strategy Overview
- 24.3.11. ScienCell Research Laboratories, Inc.
  - 24.3.11.1. Overview & Key financials
  - 24.3.11.2. Product Portfolio
  - 24.3.11.3. Profitability by Market Segments (Product/Channel/Region)
  - 24.3.11.4. Sales Footprint
  - 24.3.11.5. Analysis Commentary
  - 24.3.11.6. Strategy Overview
- 24.3.12. Kerafast
  - 24.3.12.1. Overview & Key financials
  - 24.3.12.2. Product Portfolio
  - 24.3.12.3. Profitability by Market Segments (Product/Channel/Region)
  - 24.3.12.4. Sales Footprint
  - 24.3.12.5. Analysis Commentary
  - 24.3.12.6. Strategy Overview
- 24.3.13. Takara Bio Inc.
  - 24.3.13.1. Overview & Key financials
  - 24.3.13.2. Product Portfolio
  - 24.3.13.3. Profitability by Market Segments (Product/Channel/Region)
  - 24.3.13.4. Sales Footprint
  - 24.3.13.5. Analysis Commentary
  - 24.3.13.6. Strategy Overview
- 24.3.14. Kosheeka
  - 24.3.14.1. Overview & Key financials
  - 24.3.14.2. Product Portfolio
  - 24.3.14.3. Profitability by Market Segments (Product/Channel/Region)
  - 24.3.14.4. Sales Footprint
  - 24.3.14.5. Analysis Commentary
  - 24.3.14.6. Strategy Overview

25. Assumptions and Acronyms Used

26. Research Methodology

Product Code: PMRREP32880

List of Tables

Table 01: Global Primary Hepatocytes Market Volume (Units) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 02: Global Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 03: Global Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Species
Table 04: Global Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application / Assay
Table 05: Global Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 06: Global Primary Hepatocytes Market Volume (Units) Analysis 2017-2021 and Forecast 2022-2032, By Region
Table 07: Global Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Region
Table 08: North America Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 09: North America Primary Hepatocytes Market Volume (Units) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 10: North America Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 11: North America Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Species
Table 12: North America Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application / Assay
Table 13: North America Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 14: Latin America Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 15: Latin America Primary Hepatocytes Market Volume (Units) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 16: Latin America Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 17: Latin America Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Species
Table 18: Latin America Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application / Assay
Table 19: Latin America Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 20: Europe Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 21: Europe Primary Hepatocytes Market Volume (Units) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 22: Europe Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 23: Europe Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Species
Table 24: Europe Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application / Assay
Table 25: Europe Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 26: South Asia Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 27: South Asia Primary Hepatocytes Market Volume (Units) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 28: South Asia Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 29: South Asia Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Species
Table 30: South Asia Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application / Assay
Table 31: South Asia Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 32: East Asia Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 33: East Asia Primary Hepatocytes Market Volume (Units) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 34: East Asia Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 35: East Asia Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Species
Table 36: East Asia Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application / Assay
Table 37: East Asia Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 38: Oceania Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 39: Oceania Primary Hepatocytes Market Volume (Units) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 40: Oceania Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 41: Oceania Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Species
Table 42: Oceania Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application / Assay
Table 43: Oceania Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 44: MEA Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 45: MEA Primary Hepatocytes Market Volume (Units) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 46: MEA Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 47: MEA Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Species
Table 48: MEA Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application / Assay
Table 49: MEA Primary Hepatocytes Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User

List of Figures

Figure 01: Global Primary Hepatocytes Market Volume (Units) Analysis 2017- 2021 and Forecast, 2022-2032 & Y-o-Y Growth Trend Analysis
Figure 02: Global Average Pricing Analysis Benchmark US$ per unit (2021)
Figure 03: Cryopreserved Suspension Hepatocytes Pricing Analysis (US$) for Per Unit , By Region, 2021
Figure 04: Fresh Suspension Hepatocytes Pricing Analysis (US$) for Per Unit , By Region, 2021
Figure 05: 3D (Spheroid) Hepatocytes Pricing Analysis (US$) for Per Unit , By Region, 2021
Figure 06: Expanded hepatocytes (plateable) Pricing Analysis (US$) for Per Unit , By Region, 2021
Figure 07: Non-characterized hepatocytes Pricing Analysis (US$) for Per Unit , By Region, 2021
Figure 08: Global Primary Hepatocytes Market Size (US$ Mn) Analysis, 2017-2021
Figure 09: Global Primary Hepatocytes Market Size (US$ Mn) Analysis, 2017-2032
Figure 10: Global Primary Hepatocytes Market Absolute $ Opportunity Analysis, 2022-2032
Figure 11: Global Primary Hepatocytes Market Analysis by Product-2022 & 2032
Figure 12: Global Primary Hepatocytes Market Y-o-Y Growth Projections by Product, 2022 - 2032
Figure 13: Global Primary Hepatocytes Market Attractiveness Analysis, By Product, 2022-2032
Figure 14: Global Primary Hepatocytes Market Analysis by Species-2022 & 2032
Figure 15: Global Primary Hepatocytes Market Y-o-Y Growth Projections by Species, 2022 - 2032
Figure 16: Global Primary Hepatocytes Market Attractiveness Analysis, By Species, 2022-2032
Figure 17: Global Primary Hepatocytes Market Analysis by Application / Assay-2022 & 2032
Figure 18: Global Primary Hepatocytes Market Y-o-Y Growth Projections by Application / Assay, 2022 - 2032
Figure 19: Global Primary Hepatocytes Market Attractiveness Analysis, By Application / Assay, 2022-2032
Figure 20: Global Primary Hepatocytes Market Analysis by End User-2022 & 2032
Figure 21: Global Primary Hepatocytes Market Y-o-Y Growth Projections by End User, 2022 - 2032
Figure 22: Global Primary Hepatocytes Market Attractiveness Analysis, By End User, 2022-2032
Figure 23: Global Primary Hepatocytes Market Analysis by Region-2022 & 2032
Figure 24: Global Primary Hepatocytes Market Y-o-Y Growth Projections by Region, 2022 - 2032
Figure 25: Global Primary Hepatocytes Market Attractiveness Analysis, By Region, 2022-2032
Figure 26: North America Primary Hepatocytes Market Size (US$ Mn) Analysis, 2017-2021
Figure 27: North America Primary Hepatocytes Market Size (US$ Mn) Analysis, 2021-2032
Figure 28: North America Primary Hepatocytes Market Attractiveness Analysis, By Country, 2022-2032
Figure 29: North America Primary Hepatocytes Market Attractiveness Analysis, By Product, 2022-2032
Figure 30: North America Primary Hepatocytes Market Attractiveness Analysis, By Species, 2022-2032
Figure 31: North America Primary Hepatocytes Market Attractiveness Analysis, Application/Assay, 2022-2032
Figure 32: North America Primary Hepatocytes Market Attractiveness Analysis, By End User, 2022-2032
Figure 33: Latin America Primary Hepatocytes Market Size (US$ Mn) Analysis, 2017-2021
Figure 34: Latin America Primary Hepatocytes Market Size (US$ Mn) Analysis, 2021-2032
Figure 35: Latin America Primary Hepatocytes Market Attractiveness Analysis, By Country, 2022-2032
Figure 36: Latin America Primary Hepatocytes Market Attractiveness Analysis, By Product, 2022-2032
Figure 37: Latin America Primary Hepatocytes Market Attractiveness Analysis, By Species, 2022-2032
Figure 38: Latin America Primary Hepatocytes Market Attractiveness Analysis, Application/Assay, 2022-2032
Figure 39: Latin America Primary Hepatocytes Market Attractiveness Analysis, By End User, 2022-2032
Figure 40: Europe Primary Hepatocytes Market Size (US$ Mn) Analysis, 2017-2021
Figure 41: Europe Primary Hepatocytes Market Size (US$ Mn) Analysis, 2021-2032
Figure 42: Europe Primary Hepatocytes Market Attractiveness Analysis, By Country, 2022-2032
Figure 43: Europe Primary Hepatocytes Market Attractiveness Analysis, By Product, 2022-2032
Figure 44: Europe Primary Hepatocytes Market Attractiveness Analysis, By Species, 2022-2032
Figure 45: Europe Primary Hepatocytes Market Attractiveness Analysis, Application/Assay, 2022-2032
Figure 46: Europe Primary Hepatocytes Market Attractiveness Analysis, By End User, 2022-2032
Figure 47: South Asia Primary Hepatocytes Market Size (US$ Mn) Analysis, 2017-2021
Figure 48: South Asia Primary Hepatocytes Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2021-2032
Figure 49: South Asia Primary Hepatocytes Market Attractiveness Analysis, By Country, 2022-2032
Figure 50: South Asia Primary Hepatocytes Market Attractiveness Analysis, By Product, 2022-2032
Figure 51: South Asia Primary Hepatocytes Market Attractiveness Analysis, By Species, 2022-2032
Figure 52: South Asia Primary Hepatocytes Market Attractiveness Analysis, Application/Assay, 2022-2032
Figure 53: South Asia Primary Hepatocytes Market Attractiveness Analysis, By End User, 2022-2032
Figure 54: East Asia Primary Hepatocytes Market Size (US$ Mn) Analysis, 2017-2021
Figure 55: East Asia Primary Hepatocytes Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2021-2032
Figure 56: East Asia Primary Hepatocytes Market Attractiveness Analysis, By Country, 2022-2032
Figure 57: East Asia Primary Hepatocytes Market Attractiveness Analysis, By Product, 2022-2032
Figure 58: East Asia Primary Hepatocytes Market Attractiveness Analysis, By Species, 2022-2032
Figure 59: East Asia Primary Hepatocytes Market Attractiveness Analysis, Application/Assay, 2022-2032
Figure 60: East Asia Primary Hepatocytes Market Attractiveness Analysis, By End User, 2022-2032
Figure 61: Oceania Primary Hepatocytes Market Size (US$ Mn) Analysis, 2017-2021
Figure 62: Oceania Primary Hepatocytes Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2021-2032
Figure 63: Oceania Primary Hepatocytes Market Attractiveness Analysis, By Country, 2022-2032
Figure 64: Oceania Primary Hepatocytes Market Attractiveness Analysis, By Product, 2022-2032
Figure 65: Oceania Primary Hepatocytes Market Attractiveness Analysis, By Species, 2022-2032
Figure 66: Oceania Primary Hepatocytes Market Attractiveness Analysis, Application/Assay, 2022-2032
Figure 67: Oceania Primary Hepatocytes Market Attractiveness Analysis, By End User, 2022-2032
Figure 68: MEA Primary Hepatocytes Market Size (US$ Mn) Analysis, 2017-2021
Figure 69: MEA Primary Hepatocytes Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2021-2032
Figure 70: MEA Primary Hepatocytes Market Attractiveness Analysis, By Country, 2022-2032
Figure 71: MEA Primary Hepatocytes Market Attractiveness Analysis, By Product, 2022-2032
Figure 72: MEA Primary Hepatocytes Market Attractiveness Analysis, By Species, 2022-2032
Figure 73: MEA Primary Hepatocytes Market Attractiveness Analysis, Application/Assay, 2022-2032
Figure 74: MEA Primary Hepatocytes Market Attractiveness Analysis, By End User, 2022-2032
Figure 75: Global Primary Hepatocytes Market Value Proportion Analysis, By Countries, 2022
Figure 76: Global Primary Hepatocytes Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2022-2032
Figure 77: U.S. Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 78: U.S. Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 79: U.S. Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 80: U.S. Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 81: Canada Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 82: Canada Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 83: Canada Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 84: Canada Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 85: Brazil Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 86: Brazil Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 87: Brazil Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 88: Brazil Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 89: Argentina Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 90: Argentina Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 91: Argentina Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 92: Argentina Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 93: Mexico Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 94: Mexico Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 95: Mexico Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 96: Mexico Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 97: U.K Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 98: U.K Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 99: U.K Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 100: U.K Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 101: Germany Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 102: Germany Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 103: Germany Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 104: Germany Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 105: France Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 106: France Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 107: France Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 108: France Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 109: Italy Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 110: Italy Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 111: Italy Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 112: Italy Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 113: Spain Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 114: Spain Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 115: Spain Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 116: Spain Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 117: Russia Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 118: Russia Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 119: Russia Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 120: Russia Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 121: BENELUX Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 122: BENELUX Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 123: BENELUX Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 124: BENELUX Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 125: China Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 126: China Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 127: China Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 128: China Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 129: Japan Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 130: Japan Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 131: Japan Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 132: Japan Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 133: South Korea Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 134: South Korea Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 135: South Korea Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 136: South Korea Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 137: India Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 138: India Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 139: India Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 140: India Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 141: Thailand Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 142: Thailand Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 143: Thailand Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 144: Thailand Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 145: Indonesia Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 146: Indonesia Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 147: Indonesia Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 148: Indonesia Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 149: Malaysia Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 150: Malaysia Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 151: Malaysia Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 152: Malaysia Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 153: Australia Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 154: Australia Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 155: Australia Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 156: Australia Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 157: New Zealand Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 158: New Zealand Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 159: New Zealand Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 160: New Zealand Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 161: Turkey Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 162: Turkey Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 163: Turkey Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 164: Turkey Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 165: GCC Countries Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 166: GCC Countries Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 167: GCC Countries Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 168: GCC Countries Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 169: South Africa Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 170: South Africa Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 171: South Africa Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 172: South Africa Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032
Figure 173: North Africa Primary Hepatocytes Market Share Analysis (%) By Product, 2022 & 2032
Figure 174: North Africa Primary Hepatocytes Market Share Analysis (%) By Species, 2022 & 2032
Figure 175: North Africa Primary Hepatocytes Market Share Analysis (%) By Application/Assay, 2022 & 2032
Figure 176: North Africa Primary Hepatocytes Market Share Analysis (%) By End User, 2022 & 2032

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ

SELECT AN OPTION

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ

Questions? Please give us a call or visit the contact form.

Market Study on Primary Hepatocytes: Cryopreserved Suspension Hepatocytes Hold Over 40% Market Share

Description

Table of Contents

List of Tables

Research Methodology

Table of Contents

1. Executive Summary

2. Market Overview

3. Key Market Trends

4. Key Inclusions

5. Market Background

6. COVID19 Crisis Analysis

7. Global Primary Hepatocytes Market Demand (in Volume) Analysis 2017-2021 and Forecast, 2022-2032

8. Global Primary Hepatocytes Market - Pricing Analysis

9. Global Primary Hepatocytes Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

10. Global Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032, By Product

11. Global Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032, by Species

12. Global Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032, by Application/Assay

13. Global Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032, by End User

14. Global Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032, by Region

15. North America Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032

16. Latin America Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032

17. Europe Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032

18. South Asia and Pacific Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032

19. East Asia Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032

20. Oceania Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032

21. Middle East and Africa Primary Hepatocytes Market Analysis 2017-2021 and Forecast 2022-2032

22. Country Level Primary Hepatocytes Market Analysis 2022 & 2032

23. Market Structure Analysis

24. Competition Analysis

25. Assumptions and Acronyms Used

26. Research Methodology

List of Tables

List of Figures